The enteric toxins of Clostridium perfringens
The Gram-positive pathogenClostridium perfringens is a major cause of human and veterinary enteric disease largely because this bacterium can produce several toxins when present inside the gastrointestinal tract. The enteric toxins of C. perfringens share two common features: (1) they are all single polypeptides of modest (~25—35 kDa) size, although lacking in sequence homology, and (2) they generally act by forming pores or channels in plasma membranes of host cells. These enteric toxins include C. perfringens enterotoxin (CPE), which is responsible for the symptoms of a common human food poisoning and acts by forming pores after interacting with intestinal tight junction proteins. Two other C. perfringens enteric toxins, ɛ-toxin (a bioterrorism select agent) and β-toxin, cause veterinary enterotoxemias when absorbed from the intestines; β- and ɛ-toxins then apparently act by forming oligomeric pores in intestinal or extra-intestinal target tissues. The action of a newly discovered C. perfringens enteric toxin, β2 toxin, has not yet been defined but precedent suggests it might also be a pore-former. Experience with other clostridial toxins certainly warrants continued research on these C. perfringens enteric toxins to develop their potential as therapeutic agents and tools for cellular biology.
KeywordsMDCK Cell Clostridium Perfringens Small Complex Clostridium Perfringens Enterotoxin Rabbit Ileum
Unable to display preview. Download preview PDF.
- Chakrabarti G, McClane BA (2004) The importance of calcium, calmodulin and calpain for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell Microbiol (in press)Google Scholar
- Hanna PC, Mietzner TA, Schoolnik GK, McClane BA (1991) Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. J Biol Chem 266:11037–11043PubMedGoogle Scholar
- Jolivet-Renaud C, Popoff MR, Vinit MA, Ravisse P, Moreau H, Alouf JE (1986) Enteropathogenicity of Clostridium perfringens beta toxin and other clostridial toxins. Zbl. Bakteriol S15:145–151Google Scholar
- Labbe RG (1989) Clostridium perfringens. In: Doyle MP (ed) Foodborne bacterial pathogens. Marcel Dekker Press, New York, pp 192–234Google Scholar
- McClane BA, Lyerly D, Wilkins T (2000) Enterotoxic Clostridia. In: V. A. Fischetti N, R., Ferretti, J., Portnoy, D., Rood, J. (ed) Gram-Positive Pathogens. ASM Press, Washington, D.CGoogle Scholar
- McDonel JL, Dorner F (1986) The role of toxins in bacterial pathogenesis. In: Dorner F, Drews, J. (ed) Pharmacology of Bacterial Toxins. Pergamon Press, Oxford, England; New YorkGoogle Scholar
- McDonel JL, Chang LW, Pounds JG, Duncan CL (1978) The effects of Clostridium perfringens enterotoxin on rat and rabbit ileum: an electron microscopic study. Lab Invest 39:210–218Google Scholar
- Sakurai J (1995) Toxins of Clostridium perfringens. Rev Med Microbiol 6:175–185Google Scholar
- Sarker MR, Carman RJ, McClane BA (1999) Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol Microbiol 33:946–958PubMedCrossRefGoogle Scholar
- Waters M, Savoie A, Garmory HS, Bueschel D, Popoff MR, Songer JG, Titball RW, McClane BA, Sarker MR (2003) Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets. J Clin Microbiol 41:3584–3591PubMedCrossRefGoogle Scholar